Expensify EXFY Shows Modest Gains as Stock Tests Key Resistance at 123 Finolex Industries Receives Buy Rating No Major Capex Planned for FY27 AIMD Q1 2025 Earnings Net Loss per Share of 021 Reflects Continued ClinicalStage Investment Steel Stocks Surge as Government Extends Minimum Import Price on 66 Products